Healthcare Jun 23, 2022 10:20 AM (GMT+8) · EqualOcean
Huashen Zhiyao is committed to building an artificial intelligence scientific computing platform. In combination with self-developed high-throughput biological experimental technology, it provides drug R & D personnel with an intelligent system for micro world molecular computing, simulation and design. At present, the company has developed a variety of revolutionary and innovative algorithms for protein drug design and modeling, integrated them with the high-throughput experimental platform, and completed the high-efficiency iterative closed loop of AI design / experimental verification. With the gradual improvement of platform technology, Huashen Zhiyao has begun to lay out multiple macromolecular and immunotherapy R & D pipelines, and is looking forward to rapidly advancing to the clinical stage

This text is a result of machine translation.